
Loading, please wait...

Loading, please wait...

Ghana recently joined other African nations in declining a major health partnership with the United States. This decision highlights growing health data privacy concerns across the continent. According to officials, the proposed deal lacked sufficient safeguards for sensitive citizen information. Consequently, Ghana has prioritized national data sovereignty over significant foreign funding.
The proposed agreement was worth approximately $300 million over five years. However, the Ghanaian Data Protection Commission identified several legal and ethical breaches. Specifically, the deal would have granted up to 10 US entities access to national health datasets. Furthermore, these entities would not have needed prior approval from the Ghanaian government. Instead, the US would simply notify the country after data utilization. Therefore, officials argued that this arrangement effectively outsourced the nation's health architecture. Moreover, the scope of access extended beyond raw data to include dashboards and data models.
Ghana is the latest country to walk away from the \"America First\" global health funding model. For instance, Zimbabwe rejected a similar proposal earlier this year. Zambia is also currently reviewing sections of its draft agreement with significant skepticism. Activists claim these deals often lack adequate protections for pathogen and genomic information. Additionally, some agreements are viewed as overly restrictive regarding which healthcare providers receive support. As a result, the Africa CDC has expressed major concerns regarding international data sharing. Ghana now seeks improved terms that respect local governance and citizen privacy.
Q1: Why did Ghana reject the US health agreement?
Ghana rejected the deal primarily due to health data privacy concerns. The agreement would have allowed foreign access to sensitive data without adequate local oversight or prior approval.
Q2: How much funding was involved in the rejected Ghana-US deal?
The deal was worth about $300 million total. It included $109 million in direct US funding over five years to fight diseases like malaria and HIV/AIDS.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ghana joins Zimbabwe in rejecting a US health deal due to health data privacy concerns and lack of oversight regarding sensitive citizen information....
4 months ago

A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today

A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today

A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday

The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today